The Ocular Hemodynamic Response to Nitric Oxide Synthase Inhibition is Unaltered in Patients with Early Type I Diabetes

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2003 Jul 2

PMID 12836035

Citations 4

Authors

Guido T Dorner

Gerhard Garhofer

Nicole Selenko

Peter Fasching

Michaela Bayerle-Eder

Leopold Schmetterer

Michael Wolzt

Affiliations

Soon will be listed here.

Abstract

Background: An impaired ocular hemodynamic response to systemic nitric oxide synthesis inhibition has been demonstrated in patients with long-standing insulin-dependent diabetes mellitus. It is unclear whether this altered responsiveness is already detectable in early uncomplicated type I diabetes.

Methods: The effect of the nitric oxide synthase inhibitor N(G)-monomethyl- l-arginine (L-NMMA) was studied in 10 male patients with early type I diabetes under euglycemic conditions and 10 healthy matched control subjects in a single (analyst) blinded cohort study design. Changes in ocular hemodynamics (fundus pulsation amplitude, mean flow velocity in the ophthalmic artery) and in pulse rate and mean blood pressure were measured in response to systemic intravenous doses of 1.5, 3, and 6 mg/kg L-NMMA.

Results: L-NMMA dose-dependently and significantly decreased fundus pulsation amplitude (-21.0% vs -23.3% in diabetics and controls, respectively), mean flow velocity in the ophthalmic artery (-12.3% vs -10.8%) and pulse rate (-15.4% vs -16.6%) and increased mean arterial pressure (+19.5% vs +14.7%). The ocular and systemic hemodynamic effects of L-NMMA were not different between patients with diabetes and controls.

Conclusion: The responsiveness of the choroidal vasculature and the ophthalmic artery to L-NMMA is not altered in early type 1 diabetes. An impaired hemodynamic response to nitric oxide synthesis inhibition in diabetes is therefore not caused by a primary defect but rather due to altered vascular responsiveness secondary to long-standing disease.

Citing Articles

The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.

Petersen L, Bek T Graefes Arch Clin Exp Ophthalmol. 2016; 254(12):2339-2346.

PMID: 27270566 DOI: 10.1007/s00417-016-3399-6.

Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals.

Reimann M, Vilser W, Gruber M, Bornstein S, Ziemssen T Diabetologia. 2015; 58(9):2154-60.

PMID: 26003327 DOI: 10.1007/s00125-015-3639-z.

Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition.

Granstam S, Granstam E J Physiol Sci. 2011; 61(6):497-505.

PMID: 21881977 PMC: 3204103. DOI: 10.1007/s12576-011-0171-x.

[Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Garweg J, Wenzel A Ophthalmologe. 2010; 107(7):628-35.

PMID: 20533047 DOI: 10.1007/s00347-010-2176-x.

References

Hannedouche T, Marques L, Natov S, Delgado A, Boitard C, Lacour B . Renal abnormalities in normotensive insulin-dependent diabetic offspring of hypertensive parents. Hypertension. 1992; 19(4):378-84. DOI: 10.1161/01.hyp.19.4.378. View

Radomski M, Palmer R, Moncada S . The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun. 1987; 148(3):1482-9. DOI: 10.1016/s0006-291x(87)80299-1. View

Clarkson P, Celermajer D, Donald A, Sampson M, Sorensen K, Adams M . Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996; 28(3):573-9. DOI: 10.1016/0735-1097(96)82380-1. View

Alder V, Su E, Yu D, Cringle S, Yu P . Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol. 1997; 24(9-10):785-8. DOI: 10.1111/j.1440-1681.1997.tb02133.x. View

Calver A, Collier J, Vallance P . Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992; 90(6):2548-54. PMC: 443414. DOI: 10.1172/JCI116149. View

Huvers F, de Leeuw P, Houben A, de Haan C, Hamulyak K, Schouten H . Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes. 1999; 48(6):1300-7. DOI: 10.2337/diabetes.48.6.1300. View

Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A . Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996; 94(6):1298-303. DOI: 10.1161/01.cir.94.6.1298. View

Schmetterer L, Wolzt M . Laser interferometric investigations of pulsatile choroidal blood flow: review and new results on the validity of the technique. J Biomed Opt. 2012; 3(3):246-52. DOI: 10.1117/1.429888. View

Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Findl O . The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res. 1997; 64(3):305-12. DOI: 10.1006/exer.1996.0213. View

10.

Pieper G . Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998; 31(5):1047-60. DOI: 10.1161/01.hyp.31.5.1047. View

11.

Chan N, Vallance P, Colhoun H . Nitric oxide and vascular responses in Type I diabetes. Diabetologia. 2001; 43(2):137-47. DOI: 10.1007/s001250050022. View

12.

Balletshofer B, Rittig K, Enderle M, Volk A, Maerker E, Jacob S . Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000; 101(15):1780-4. DOI: 10.1161/01.cir.101.15.1780. View

13.

Schmetterer L, Findl O, Strenn K, Fasching P, Zanaschka G, Eichler H . Ocular and systemic reactivity to isoprenaline in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997; 27(9):750-4. DOI: 10.1046/j.1365-2362.1997.1830731.x. View

14.

Schmetterer L, Muller M, Fasching P, Diepolder C, Gallenkamp A, Zanaschka G . Renal and ocular hemodynamic effects of insulin. Diabetes. 1997; 46(11):1868-74. DOI: 10.2337/diab.46.11.1868. View

15.

Brands M, Hopkins T . Poor glycemic control induces hypertension in diabetes mellitus. Hypertension. 1996; 27(3 Pt 2):735-9. DOI: 10.1161/01.hyp.27.3.735. View

16.

Berry K, Skyrme-Jones R, Cameron J, OBrien R, Meredith I . Systemic arterial compliance is reduced in young patients with IDDM. Am J Physiol. 1999; 276(6):H1839-45. DOI: 10.1152/ajpheart.1999.276.6.H1839. View

17.

JORGENSEN R, Russo L, Mattioli L, Moore W . Early detection of vascular dysfunction in type I diabetes. Diabetes. 1988; 37(3):292-6. DOI: 10.2337/diab.37.3.292. View

18.

Schmetterer L, Findl O, Fasching P, FERBER W, Strenn K, Breiteneder H . Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 1997; 46(4):653-8. DOI: 10.2337/diab.46.4.653. View

19.

Gardiner S, Compton A, Bennett T, Palmer R, Moncada S . Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990; 15(5):486-92. DOI: 10.1161/01.hyp.15.5.486. View

20.

Fuchsjager-Mayrl G, Kautzky-Willer A, Kiss B, Roden M, Wagner O, Pleiner J . Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes. Diabetologia. 2002; 45(6):883-9. DOI: 10.1007/s00125-002-0848-z. View